This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Active as of 2022-09-19 |
Resource Evidence "104396" Version "11" Updated "2023-12-06 00:47:22+0000"
Profiles: ComparatorOnlyEvidence, SingleStudyEvidence
StructureDefinition Work Group: cds
url: https://fevir.net/resources/Evidence/104396
identifier: FEvIR Object Identifier: 104396
version: 1.0.0-ballot
name: ComparatorOnlyEvidence_Remission_of_diabetes_without_bariatric_surgery_Control_Group_in_JAMA_2018_Norwegian_cohort_study
title: ComparatorOnlyEvidence: Remission of diabetes without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study
status: active
date: 2022-09-19 21:15:57+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
author: Brian S. Alper:
Code | Value[x] |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | ComparatorOnlyEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#ComparatorOnlyEvidence) |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | SingleStudyEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#SingleStudyEvidence) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: derived-from
document
relatedArtifact
type: cite-as
citation: ComparatorOnlyEvidence: Remission of diabetes without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study [Evidence]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 104396. Revised 2022-09-19. Available at: https://fevir.net/resources/Evidence/104396. Computable resource at: https://fevir.net/resources/Evidence/104396.
description: Risk of Remission of diabetes in control group was 14.8%.
variableDefinition
VariableDefinitionVariableRoleCode: population
description: Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included). -- Comparator Group assigned to no bariatric surgery (specialized medical treatment without bariatric surgery (control group))
note: population
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#population "population")
observed: Group/172939: ComparatorGroup: JAMA 2018 Norwegian cohort study Control cohort "ComparatorGroup_JAMA_2018_Norwegian_cohort_study_Control_cohort"
variableDefinition
VariableDefinitionVariableRoleCode: outcome
description: Remission of diabetes
note: outcome
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#measuredVariable "measured variable")
observed: EvidenceVariable/104117: OutcomeVariable: Remission of diabetes "OutcomeVariable_Remission_of_diabetes"
synthesisType: not applicable (StatisticSynthesisType#NotApplicable)
studyDesign: Observational research (Study Design#SEVCO:01002), Parallel cohort design (Study Design#SEVCO:01011), Longitudinal data collection (Study Design#SEVCO:01028)
statistic
description: 141 out of 956 observed with percentage of: 14.8%
statisticType: Proportion (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#TBD:0000018)
quantity: 0.148
numberAffected: 141
SampleSizes
NumberOfStudies NumberOfParticipants KnownDataCount 1 956 956